Technetium- and rhenium- bis (heteroaryl) complexes and methods of use thereof for inhibiting psma

作者: John Joyal , John W. Babich , Genliang Lu , Shawn Hillier , Craig Zimmerman

DOI:

关键词: Salt (chemistry)TechnetiumCombinatorial chemistryCancerNuclear chemistryRheniumChemistryMetal

摘要: A compound of Formula (I), a pharmaceutically acceptable salt, or solvate thereof, complexes with metals such as rhenium, technetium, and others to provide complex for imaging tissues treating disease, particularly where the metal is radioactive. Such are specific PSMA protein can therefore be used in cancer prostate other tissue expressed.

参考文章(58)
John W. Babich, Craig N. Zimmerman, Inhibitors of integrin vla-4 ,(2008)
Jaime L. Masferrer, Janet M. O'neal, Methods for treating carbonic anhydrase mediated disorders ,(2003)
Hiroshi Ochiai, Yoshikazu Takaoka, Shiro Shibayama, Masaya Kokubo, Basic group-containing compound and use thereof ,(2006)
John W. Babich, Kevin P. Maresca, Technetium-dipyridine complexes, and methods of use thereof ,(2003)
Thomas Frenzel, Heribert Schmitt-Willich, Heiko Schirmer, Hans Bauer, Detlev Sulzle, Bernd Raduchel, Johannes Platzek, Hanns-Joachim Weinmann, Gunther Michl, Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy ,(2002)
Takeru Higuchi, Drug-delivery device ,(1970)
John Joyal, John W. Babich, Craig N. Zimmerman, Genliang Lu, Shawn Hillier, Kevin P. Maresca, CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer ,(2009)